European Archives - Page 358 of 1178 - European Medical Journal

Liver Resection Improves Survival Outcomes in Early Liver Cancer

A study has linked liver resection to improved survival outcomes in patients with early liver cancer, finding that the 5-year overall survival rate almost doubled in patients who had undergone LR compared to non-surgical treatments

Superior Post-Transplant Outcomes for Female Liver Recipients Compared to Males

Females demonstrate superior survival rates than males following liver transplantation, according to a recent study

Undiagnosed Asthma and COPD Explored in Randomized Controlled Trial: Late-Breaking Abstract From ATS 2024

New study results highlight the effect of early diagnosis and treatment of undiagnosed asthma or chronic obstructive pulmonary disease.

Increased Bleeding Risk in Patients with COVID-19 with Prior Pulmonary Embolism: Late-Breaking Abstract From ATS 2024

A recent multicenter study has uncovered critical insights into the risks faced by patients with a history of acute pulmonary embolism during the COVID-19 pandemic.

Androgen Deprivation Therapy in Prostate Cancer: A Practical Approach to Complex Clinical Scenarios

Vilaseca opened the meeting by reminding the audience that the management and treatment of advanced PCa has…

Bacterial Infection Hospitalisations Linked To Drug Use-Associated Infective Endocarditis

Long-term risk of mortality and hospitalisation is a consequence of bacterial infection in survivors of drug use-associated infective endocarditis

EMJ Urology 12 [Supplement 1] 2024

Androgen deprivation therapy (ADT) continues to be central to the treatment of advanced prostate cancer (PCa). This article summarises…

Childhood Hypertension Associated with Long-Term Cardiovascular Disease Risk

New research has found an association between hypertension in youths and a 2.1 times higher risk of major adverse cardiac events

Racial and Gender Disparities in Melanoma Outcomes

Research has found significant disparities in melanoma presentations and outcomes between non-Hispanic Black and non-Hispanic White patients.

Higher Initial Dosing of Propranolol Safe in Infant Haemangioma

A study has shown that initiating propranolol at 2mg/kg/day does not increase the risk of adverse events compared to the standard 1mg start dose in treating infantile haemangiomas.